RECENT ADVANCES IN INFLAMMATION & ALLERGY DRUG DISCOVERY : Impact Factor & More
eISSN: 2772-2708pISSN: 2772-2716
Share this on:
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
RECENT ADVANCES IN INFLAMMATION & ALLERGY DRUG DISCOVERY Journal Specifications
| Overview | |
| Publisher | BENTHAM SCIENCE PUBL LTD |
| Frequency | Semi-annual |
| General Details |
View less
Planning to publish in RECENT ADVANCES IN INFLAMMATION & ALLERGY DRUG DISCOVERY ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
FAQs on RECENT ADVANCES IN INFLAMMATION & ALLERGY DRUG DISCOVERY
What is the publishing frequency of RECENT ADVANCES IN INFLAMMATION & ALLERGY DRUG DISCOVERY? 
What is the eISSN & pISSN for RECENT ADVANCES IN INFLAMMATION & ALLERGY DRUG DISCOVERY?
Who is the publisher of RECENT ADVANCES IN INFLAMMATION & ALLERGY DRUG DISCOVERY?
Check if your manuscript is a good match for
undefined
Upload your manuscript to get recommendations of journals
that have published papers similar to your manuscript
Drag and drop your file here
We accept manuscripts in English. File format: .doc and .docx | Maximum size: 10 MB | Word count: 200-300,000 words | File length: less than 100 pages
Do not have a manuscript right now? Use an abstract or summary
Your document is 100% secure & confidential We use 256-bit encryption for total security and
ISO/IEC 27001:2013 Certified
What all does the report include
01. Degree of Match
02. Common Topics
03. Additional
Recommendations
Recommendations